Bernstein trims AstraZeneca target to 198 pounds
Bernstein cut its price target on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker's long-term outlook. Shares in AstraZeneca were up 1% at 120.80 pounds.
Bernstein cut its price target on AstraZeneca to 198 pounds from 200 pounds and kept a positive view on the drugmaker's long-term outlook. Shares in AstraZeneca were up 1% at 120.80 pounds.